Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
Tema
Enfermedad de Parkinson
2346 ARTíCULOS , VIENDO DEL 2221 AL 2235
Deep-brain-stimulation does not impair deglutition in Parkinson's disease.
Lengerer S, Kipping J, Rommel N, Weiss D, Breit S, Gasser T, Plewnia C, Krüger R, Wächter T.
Parkinsonism Relat Disord. 2012 Aug;18(7):847-53. doi: 10.1016/j.parkreldis.2012.04.014.
0
0
0
[Essential tremor and Parkinson's disease: are they associated?].
Labiano-Fontcuberta A, Benito-León J.
Rev Neurol. 2012 Oct 16;55(8):479-89. Review. Spanish.
0
0
0
Chelators in the treatment of iron accumulation in Parkinson's disease.
Mounsey RB, Teismann P.
Int J Cell Biol. 2012;2012:983245. doi: 10.1155/2012/983245.
0
0
0
Ojo OO, Okubadejo NU, Ojini FI, Danesi MA.
Niger Med J. 2012 Apr;53(2):65-70. doi: 10.4103/0300-1652.103544.
0
0
0
In search of an immunobiomarker for Parkinson's disease.
Chang L.
J Neuroimmune Pharmacol. 2012 Dec;7(4):719-21. doi: 10.1007/s11481-012-9415-7. No abstract available.
0
0
0
Characterization of mitophagy in the 6-hydoxydopamine Parkinson's disease model.
Solesio ME, Saez-Atienzar S, Jordán J, Galindo MF.
Toxicol Sci. 2012 Oct;129(2):411-20. doi: 10.1093/toxsci/kfs218.
0
0
0
Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond.
Perier C, Bové J, Vila M.
Antioxid Redox Signal. 2012 May 1;16(9):883-95. doi: 10.1089/ars.2011.4074. Review.
0
0
0
[The cutting-edge of medicine: diagnosis and treatment of Parkinson's disease in clinical practice].
Nomoto M.
Nihon Naika Gakkai Zasshi. 2012 Jul 10;101(7):2065-71. Japanese. No abstract available.
0
0
0
Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
Semenova EV, Shadrina MI, Slominsky PA, Ivanova-Smolenskaya IA, Bagyeva G, Illarioshkin SN, Limborska SA.
Mov Disord. 2012 Jan;27(1):139-42. doi: 10.1002/mds.23901.
0
0
0
Α-synuclein misfolding and Parkinson's disease.
Breydo L, Wu JW, Uversky VN.
Biochim Biophys Acta. 2012 Feb;1822(2):261-85. doi: 10.1016/j.bbadis.2011.10.002. Review.
0
0
0
Ravizza SM, Goudreau J, Delgado MR, Ruiz S.
Cogn Affect Behav Neurosci. 2012 Mar;12(1):193-206. doi: 10.3758/s13415-011-0066-6.
0
0
0
Cognitive impairments in Parkinson's disease: Evidence from an Iranian population.
Ashrafi F, Zali A, Pakdaman H, Johari K.
Iran J Neurol. 2012;11(4):151-4.
0
0
0
Recurrent delirium caused by concealed Wolff-Parkinson-White syndrome in a 77 year old woman.
Lillebø ML, Velle HO, Wyller TB.
Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):426-9. doi: 10.4045/tidsskr.11.0119. English, Norwegian.
0
0
0
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T.
Mov Disord. 2012 Apr 15;27(5):617-26. doi: 10.1002/mds.24996. Review.
0
0
0
Dementia is associated with insulin resistance in patients with Parkinson's disease.
Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, Mungari P, Fonte G, Consoli D, Consoli A, Fava A.
J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
